Feb 6 (Reuters) - Alumis Inc ( ALMS ):
* ALUMIS AND ACELYRIN TO MERGE CREATING A LATE-STAGE
CLINICAL
BIOPHARMA COMPANY DEDICATED TO INNOVATING, DEVELOPING AND
COMMERCIALIZING TRANSFORMATIVE THERAPIES FOR IMMUNE-MEDIATED
DISEASES
Source text:
Further company coverage: